(Q24304160)

5-hydroxytryptamine receptor 2B

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

N Dizeyi

1

0 references

A Bjartell

2

0 references

P Hedlund

3

0 references

K A Taskén

4

0 references

V Gadaleanu

5

0 references

P-A Abrahamsson

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

6

0 references

language of work or name

English

0 references

publication date

June 2005

0 references

published in

European Urology

0 references

volume

47

0 references

page(s)

895-900

0 references

issue

6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Serotonin as a growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Molecular, pharmacological and functional diversity of 5-HT receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Autocrine and paracrine signaling through neuropeptide receptors in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Ras involvement in signal transduction by the serotonin 5-HT2B receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Hyper-responsiveness to 5-HT2Agonists by Tumour-linked Arterioles in Mice: Consequences for Tumour Growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Effects of serotonin and vasopressin on cortisol production from an adrenocortical tumor causing subclinical Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-I in mouse mandibular mesenchymal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021

Impact of serotonin on tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.EURURO.2005.02.006

7 January 2021